Neos Therapeutics (NEOS) Posts Wider-than-Expected Q2 Loss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Neos Therapeutics (NEOS) Posts Wider-than-Expected Q2 Loss

Neos Therapeutics Announces Second Quarter 2015 Financial Results

September 3, 2015 7:00 AM EDT

- Company appoints Beth Hecht to Board of Directors -

- Conference call scheduled for 8:30 a.m. ET today -

DALLAS & FORT WORTH, Texas--(BUSINESS WIRE)-- Neos Therapeutics, Inc. (NASDAQ: NEOS), a pharmaceutical company with a latestage pipeline of innovative extended-release (XR) product candidates for the treatment of attention deficit hyperactivity disorder (ADHD), today announced financial results for the second quarter ended June 30, 2015. The Company also announced the appointment of Beth Hecht to its Board of Directors.

Recent Highlights

... More